| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.44B | 35.34B | 39.01B | 45.28B | 37.55B | 26.73B |
| Gross Profit | 4.51B | 4.52B | 4.05B | 5.16B | 4.51B | 3.18B |
| EBITDA | 1.82B | 1.97B | 1.68B | 2.64B | 2.37B | 1.30B |
| Net Income | 1.01B | 1.05B | 848.51M | 1.64B | 1.54B | 743.01M |
Balance Sheet | ||||||
| Total Assets | 24.00B | 24.62B | 27.15B | 30.01B | 25.25B | 20.51B |
| Cash, Cash Equivalents and Short-Term Investments | 8.47B | 8.29B | 10.38B | 10.93B | 10.44B | 9.51B |
| Total Debt | 4.14B | 3.47B | 4.57B | 5.17B | 2.78B | 3.63B |
| Total Liabilities | 12.31B | 12.68B | 15.71B | 19.28B | 15.75B | 12.42B |
| Stockholders Equity | 11.70B | 11.94B | 11.44B | 10.73B | 9.49B | 8.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -624.18M | 388.98M | -1.41B | 2.02B | 2.53B |
| Operating Cash Flow | 0.00 | -277.91M | 1.19B | 1.03B | 2.35B | 2.91B |
| Investing Cash Flow | 0.00 | -361.82M | -634.05M | -2.46B | -321.52M | -431.50M |
| Financing Cash Flow | 0.00 | -1.47B | -1.11B | 1.90B | -1.09B | 2.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥28.52B | 12.78 | ― | 3.12% | 6.60% | 0.27% | |
75 Outperform | ¥14.42B | 12.16 | ― | 3.02% | 3.43% | 3.75% | |
72 Outperform | ¥56.87B | 12.54 | ― | 0.91% | 5.28% | 18.38% | |
69 Neutral | ¥9.30B | 9.45 | ― | 4.58% | -0.81% | 42.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥56.27B | -141.26 | ― | 5.01% | -32.74% | -117.06% | |
51 Neutral | ¥4.28B | -34.48 | ― | 1.79% | -10.43% | -368.47% |